SkinnyRx Review

SkinnyRx in one line: cheap, broad GLP-1 access carrying a real FDA flag

SkinnyRx, operated by Lean Rx, Inc., is a mainstream telehealth front-end for compounded GLP-1 weight-loss medication. It does the things most people in the market actually want: it offers both semaglutide and tirzepatide, it folds the clinician visit and shipping into the price, and it lands well under the brand-name pens that can run more than a thousand dollars a month elsewhere. But there is a fact you have to weigh before anything else: SkinnyRx received an FDA warning letter in early 2026. That doesn't make the medication unusable, but it changes how much benefit of the doubt the company has earned, and we cover it plainly below rather than burying it.

How the pricing actually works

SkinnyRx runs a tiered monthly model rather than a single flat fee. The standard ongoing rate lands at $149.25 per month, and that figure is meant to be all-in: the medication, the clinician consult through the patient portal, and shipping are bundled, so you're not nickel-and-dimed by a separate visit charge the way some providers do it. The company also advertises an "as low as" introductory figure that sits below the standard tier — a teaser tied to specific doses or prepay terms, not the rate most people settle into month after month. Treat the headline low number as a best-case starting point, not your steady cost.

For context, the category median across the providers we track sits near $169 per month, so SkinnyRx's standard rate is a touch above the middle of the pack — not the cheapest option, but firmly in mainstream territory and far below brand-name list prices. There's no stated long-term contract; the company markets a cancel-anytime arrangement, which is the right structure for a medication you may want to stop or switch.

The medications and how they reach you

You can get compounded semaglutide (the molecule in Ozempic and Wegovy) or compounded tirzepatide (the molecule in Mounjaro and Zepbound) — having both on the menu is genuinely useful, because tirzepatide tends to drive larger losses for many people, and not every budget provider stocks it. These are compounded versions, not the FDA-approved branded pens, which is how the price gets down to this level. Every prescription is written by a licensed U.S. clinician, the consult happens inside the patient portal at no extra cost, and the medication ships discreetly to your door with free overnight delivery advertised on orders.

• Compounded semaglutide — the lower-cost workhorse for appetite control and steady weight loss
• Compounded tirzepatide — the dual-action option many people step up to for stronger results
• Bundled clinician consult — handled through the portal, no separate visit fee
• Free overnight shipping — included rather than tacked on at checkout

The FDA warning letter — what it says and why it matters

In February 2026 the FDA issued a warning letter (number 717989) to Lean Rx, Inc., doing business as SkinnyRx. The core finding: the labeling pictured on the company's website for its compounded semaglutide and tirzepatide put the "SkinnyRx" name on the product label in a way that implies SkinnyRx is the compounder when it is not. The letter also cited additional false or misleading claims under the federal misbranding rules. You can read our full breakdown on the SkinnyRx FDA warning letter page.

Here's the honest read. This is a labeling-and-marketing citation, not a recall or a finding that the medicine itself is contaminated or dangerous. But it tells you the company was willing to present itself as the maker of a product it doesn't actually compound, and it does not name the accredited pharmacy actually filling the prescriptions. SkinnyRx lists no disclosed compounding partner in our record, which is a transparency gap on its own — and a warning letter on top of that gap is the kind of signal a careful shopper should not wave away.

Where SkinnyRx is genuinely thin: transparency

Beyond the FDA matter, the bigger practical frustration is how little SkinnyRx tells you before you hand over information. The list of states it serves is not published anywhere public — it's gated behind the signup intake, so you can't confirm it operates where you live without starting the process. Program details are similarly light on the open web; the site is a heavy, app-style page that pushes you toward an account rather than laying out specifics. None of that is disqualifying, but it means you're asked to trust first and verify later, which is the opposite of how we'd want a medical purchase to go.

Who should consider it — and who should skip it

SkinnyRx makes the most sense for a price-driven shopper who specifically wants both semaglutide and tirzepatide on one platform, wants the consult and shipping baked into a single monthly number, and is comfortable doing their own due diligence on a company carrying a recent FDA flag. The cancel-anytime structure and bundled pricing are real conveniences for that buyer.

Skip it if you want maximum transparency and a clean compliance record. If you'd feel uneasy not knowing which pharmacy compounds your medication, or you want a provider that publishes its service-area and program terms up front, you have lower-risk options at a similar price. Anyone who prioritizes brand-name Wegovy or Zepbound over a compounded formula should also look elsewhere — SkinnyRx is a compounded-only play.

Bottom line

SkinnyRx delivers the mainstream essentials — both major GLP-1 molecules, U.S. clinicians, all-in monthly pricing around $149.25, free overnight shipping, and no lock-in — at a fair, middle-of-the-market rate. What keeps it out of our top tier is trust, not value: a 2026 FDA warning letter over misleading labeling, an undisclosed compounding pharmacy, and a hidden state list add up to a transparency problem you should weigh seriously. If price and drug selection are your only criteria, it's a reasonable pick; if oversight and disclosure matter to you, read the warning-letter details first and compare against cleaner-record providers using our scoring methodology before you commit.

Shopping around? Gala ($149/month) and Sunlight ($88/month) are the nearest alternatives to SkinnyRx in our rankings.